We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
RenaissanceRe Holdings Ltd.’s (RNR - Free Report) third-quarter 2018 operating earnings per share of 52 cents beat the Zacks Consensus Estimate by a whopping 420%. Moreover, the bottom line reversed the year-ago period’s loss of $13.74. This upside was backed by positive net and operating income.
RenaissanceRe Holdings Ltd. Price, Consensus and EPS Surprise
The quarter under review witnessed many large catastrophic events, positive net and operating income along with growth in tangible book value per share along with other accumulated dividends.
Quarterly Operational Update
RenaissanceRe’s third-quarter operating revenues of $613 million surpassed the Zacks Consensus Estimate by 0.6%. The top line even improved 3.7% year over year, driven by higher net investment income.
Gross premiums written dipped 2.3% year over year to $626 million due to lower premiums in the Property segments. However, the downside was partially offset by the increase in premiums in the Casualty and Specialty segment.
Net investment income is $80.6 million for the reported quarter, skyrocketing 100.5% year over year.
RenaissanceRe’s total expenses were $579.4 million, down 57.3% year over year due to lower net claims and claim expenses.
Underwriting loss of $29 million was narrower than the year-ago quarter’s loss of $793.2 million.
Combined ratio was 105.5% for the third quarter compared with the year-ago quarter’s tally of 244.8%.
Quarterly Segment Update
Property Segment
Gross premiums written were $301.4 million, down 7.4% year over year, led by a decrease in premium written in catastrophe class of business.
Underwriting loss of $43.9 million due to catastrophe events that occurred in the third quarter compared favorably with the underwriting loss of $750.2 million in the prior-year period. Combined ratio of 115% improved from 322.7% a year earlier.
Casualty and Specialty Segment
Gross premiums written were $324.3 million, up 3% from the prior-year quarter, driven by continued and selective growth from new business opportunities within a few classes of business.
Underwriting income of $14.9 million declined 65.4% from the year-ago quarter’s income of $43.1 million.
Combined ratio of 93.8% improved from 120.4% by 2660 basis points in the third quarter of 2017. This upside was particularly driven by a 23.5% decrease in the net claims and claim expense ratio as a result of significant net claims and claim expenses from 2017’s third-quarter Large Loss Events.
Financial Position
As of Sep 30, 2018, total assets of RenaissanceRe were $17 billion, up 13% from 2017-end level.
The company had total debt of $990 million as of Sep 30 2018, up 0.1% from the 2017-end level.
Cash and cash equivalents were $453 million, down 66.7% from 2017 end.
Book Value per share of $105.21 inched up 0.6% year over year.
Return on equity for the quarter under review is 3.1%.
Among other players from the insurance industry having reported third-quarter earnings so far, the bottom line of The Progressive Corporation (PGR - Free Report) and MGIC Investment Corporation (MTG - Free Report) outpaced the respective Zacks Consensus Estimate while the metric of RLI Corp. (RLI - Free Report) missed the same.
3 Medical Stocks to Buy Now
The greatest discovery in this century of biology is now at the flashpoint between theory and realization. Billions of dollars in research have poured into it. Companies are already generating revenue, and cures for a variety of deadly diseases are in the pipeline.
So are big potential profits for early investors. Zacks has released an updated Special Report that explains this breakthrough and names the best 3 stocks to ride it.
Image: Bigstock
RenaissanceRe's (RNR) Q3 Earnings Beat Estimates, Rise Y/Y
RenaissanceRe Holdings Ltd.’s (RNR - Free Report) third-quarter 2018 operating earnings per share of 52 cents beat the Zacks Consensus Estimate by a whopping 420%. Moreover, the bottom line reversed the year-ago period’s loss of $13.74. This upside was backed by positive net and operating income.
RenaissanceRe Holdings Ltd. Price, Consensus and EPS Surprise
RenaissanceRe Holdings Ltd. Price, Consensus and EPS Surprise | RenaissanceRe Holdings Ltd. Quote
The quarter under review witnessed many large catastrophic events, positive net and operating income along with growth in tangible book value per share along with other accumulated dividends.
Quarterly Operational Update
RenaissanceRe’s third-quarter operating revenues of $613 million surpassed the Zacks Consensus Estimate by 0.6%. The top line even improved 3.7% year over year, driven by higher net investment income.
Gross premiums written dipped 2.3% year over year to $626 million due to lower premiums in the Property segments. However, the downside was partially offset by the increase in premiums in the Casualty and Specialty segment.
Net investment income is $80.6 million for the reported quarter, skyrocketing 100.5% year over year.
RenaissanceRe’s total expenses were $579.4 million, down 57.3% year over year due to lower net claims and claim expenses.
Underwriting loss of $29 million was narrower than the year-ago quarter’s loss of $793.2 million.
Combined ratio was 105.5% for the third quarter compared with the year-ago quarter’s tally of 244.8%.
Quarterly Segment Update
Property Segment
Gross premiums written were $301.4 million, down 7.4% year over year, led by a decrease in premium written in catastrophe class of business.
Underwriting loss of $43.9 million due to catastrophe events that occurred in the third quarter compared favorably with the underwriting loss of $750.2 million in the prior-year period. Combined ratio of 115% improved from 322.7% a year earlier.
Casualty and Specialty Segment
Gross premiums written were $324.3 million, up 3% from the prior-year quarter, driven by continued and selective growth from new business opportunities within a few classes of business.
Underwriting income of $14.9 million declined 65.4% from the year-ago quarter’s income of $43.1 million.
Combined ratio of 93.8% improved from 120.4% by 2660 basis points in the third quarter of 2017. This upside was particularly driven by a 23.5% decrease in the net claims and claim expense ratio as a result of significant net claims and claim expenses from 2017’s third-quarter Large Loss Events.
Financial Position
As of Sep 30, 2018, total assets of RenaissanceRe were $17 billion, up 13% from 2017-end level.
The company had total debt of $990 million as of Sep 30 2018, up 0.1% from the 2017-end level.
Cash and cash equivalents were $453 million, down 66.7% from 2017 end.
Book Value per share of $105.21 inched up 0.6% year over year.
Return on equity for the quarter under review is 3.1%.
Zacks Rank
RenaissanceRe carries a Zacks Rank #3 (Hold). You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.
Performance of Other Insurers
Among other players from the insurance industry having reported third-quarter earnings so far, the bottom line of The Progressive Corporation (PGR - Free Report) and MGIC Investment Corporation (MTG - Free Report) outpaced the respective Zacks Consensus Estimate while the metric of RLI Corp. (RLI - Free Report) missed the same.
3 Medical Stocks to Buy Now
The greatest discovery in this century of biology is now at the flashpoint between theory and realization. Billions of dollars in research have poured into it. Companies are already generating revenue, and cures for a variety of deadly diseases are in the pipeline.
So are big potential profits for early investors. Zacks has released an updated Special Report that explains this breakthrough and names the best 3 stocks to ride it.
See them today for free >>